Vernal keratoconjunctivitis treated with omalizumab: a case series
We report the cases of four children affected by Vernal keratoconjunctivitis (VKC) treated with Omalizumab with resolution of ocular
signs and symptoms. Vernal keratoconjunctivitis (VKC) is a chronic conjunctivitis, not responding to topical antihistamines and frequently
misdiagnosed and mistreated. The effect of Omalizumab in patients with VKC should be better investigated and well-